Crown LiquidationCo NV in liquidatie CNTGFの前四半期の収益はどうでしたか?
Crown LiquidationCo NV in liquidatieの収益見積もりはいくらですか?
Crown LiquidationCo NV in liquidatieの収益品質スコアはどれくらいですか?
Crown LiquidationCo NV in liquidatieはいつ収益を報告しますか?
Crown LiquidationCo NV in liquidatieの予想収益はいくらですか?
Crown LiquidationCo NV in liquidatieは収益予想を上回りましたか?
主要データ
前終値
$0.1151
始値
$0.105
当日レンジ
$0.105 - $0.105
52週レンジ
$0.01 - $0.705
取引高
--
平均取引高
1.0K
1株当たり利益(TTM)
-2.14
配当利回り
--
時価総額
$2.8M
CNTGFとは何ですか?
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company is headquartered in Rostock, Mecklenburg-Vorpommern and currently employs 493 full-time employees. The company went IPO on 2019-11-07. The firm focuses on rare diseases, transforming clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The firm's platform includes epidemiological, phenotypic, and genetic data reflecting a global population, as well as a biobank of blood samples from these patients. The firm's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. The firm's Clinical Diagnostics segment provides targeted genetic sequencing and diagnostic services to patients through its distribution partners and customers, which are typically physicians, laboratories or hospitals.